References
- Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
- Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
- Hogden A, Greenfield D, Nugus P, Kiernan MC. What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives. Patient Prefer Adherence. 2012;6:829–38.
- National Institute of Health and Clinical Excellence (2016). Motor neurone disease: assessment and management (NICE guideline 42). Available at: https://www.nice.org.uk/guidance/ng42.
- Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 2018;91(15)
- Elamin M, Bede P, Byrne S, Jordan L, Gallagher L, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80(17):1590–7
- Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition & behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
- Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
- Leighton D, Newton J, Colville S, Bethell A, Craig G, Cunningham L, et al. Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:242–50.
- Govaarts R, Beeldman E, Kampelmacher MJ, van Tol M-J, van den Berg LH, van der Kooi AJ, et al. The frontotemporal syndrome of ALS is associated with poor survival. J Neurol. 2016;263:2476–83.
- Martin NH, Landau S, Janssen A, Lyall R, Higginson I, Burman R, et al. Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population study. ALS-FTD J. 2014;15:376–87.